Linsong Chen

机构：Shanghai Pulmonary Hospital, Ministry of Transport, CCCC Wuhan Harbour Engineering Design and Research (China)

发表论文 41 篇 · 总被引 740 次 · h-index 12

代表论文

• Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC (2021 · Theranostics · 被引 20)
• Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes (2024 · The Journal of Gene Medicine · 被引 16)
• Rivaroxaban versus nadroparin for thromboprophylaxis following thoracic surgery for lung cancer: A randomized, noninferiority trial (2023 · American Journal of Hematology · 被引 16)
• Bevacizumab‐Laden Nanofibers Simulating an Antiangiogenic Niche to Improve the Submuscular Stability of Stem Cell Engineered Cartilage (2022 · Small · 被引 16)
• Inhalable Lipid Nanoparticles with Mucus Clearance and ROS Scavenging Properties for Acute Lung Injury Treatment (2025 · Advanced Functional Materials · 被引 9)
• Hemoglobin‐Mediated Dual‐Crosslinked Silk Fibroin With Enhanced Elasticity, Rigidity, Toughness, and Shapeability for Tracheal Tissue Application (2025 · Advanced Functional Materials · 被引 7)